Found: 10
Select item for more details and to access through your institution.
Experimental and Numerical Study of Pd/Ta and PdCu/Ta Composites for Thermocatalytic Hydrogen Permeation.
- Published in:
- Membranes, 2023, v. 13, n. 1, p. 23, doi. 10.3390/membranes13010023
- By:
- Publication type:
- Article
Tyrosol Suppresses Allergic Inflammation by Inhibiting the Activation of Phosphoinositide 3-Kinase in Mast Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129829
- By:
- Publication type:
- Article
SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00050
- By:
- Publication type:
- Article
Discovery of 2,3-Dihydro-1 H-indene Derivatives as Novel GPR40 Agonists.
- Published in:
- Bulletin of the Korean Chemical Society, 2017, v. 38, n. 8, p. 861, doi. 10.1002/bkcs.11185
- By:
- Publication type:
- Article
SG-HQ2 inhibits mast cell-mediated allergic inflammation through suppression of histamine release and pro-inflammatory cytokines.
- Published in:
- Experimental Biology & Medicine, 2015, v. 240, n. 5, p. 631, doi. 10.1177/1535370214555663
- By:
- Publication type:
- Article
124-LB: Development of IDG-16177, a Selective and Safe GPR40 Agonist for the Treatment of Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-124-LB
- By:
- Publication type:
- Article
123-LB: IDG-16177, a Potent, Orally-Bioavailable GPR40 Agonist, Improves Glycemic Control and Glucose-Stimulated Insulin Secretion in Preclinical Studies.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-123-LB
- By:
- Publication type:
- Article
122-LB: In Vitro Pharmacodynamic Studies of IDG-16177, a Potent GPR40 Agonist, for the Treatment of Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-122-LB
- By:
- Publication type:
- Article
644-P: Discovery of Nonpeptide, Orally Available Small Molecule GLP-1 Receptor Agonists.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-644-P
- By:
- Publication type:
- Article
118-LB: Preclinical Development of IDG-16177 as a Potent GPR40 Agonist for Treatment of Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-118-LB
- By:
- Publication type:
- Article